CAM
Cormorant Asset Management’s X4 Pharmaceuticals XFOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-54,299
| Closed | -$1.42M | – | 75 |
|
|
2023
Q1 | $1.42M | Hold |
54,299
| – | – | 0.09% | 62 |
|
|
2022
Q4 | $1.62M | Buy |
54,299
+26,611
| +96% | +$793K | 0.11% | 61 |
|
|
2022
Q3 | $1.42M | Buy |
27,688
+24,222
| +699% | +$1.24M | 0.1% | 62 |
|
|
2022
Q2 | $100K | Hold |
3,466
| – | – | 0.01% | 79 |
|
|
2022
Q1 | $182K | Hold |
3,466
| – | – | 0.01% | 77 |
|
|
2021
Q4 | $238K | Hold |
3,466
| – | – | 0.01% | 77 |
|
|
2021
Q3 | $550K | Hold |
3,466
| – | – | 0.02% | 85 |
|
|
2021
Q2 | $676K | Hold |
3,466
| – | – | 0.02% | 94 |
|
|
2021
Q1 | $895K | Hold |
3,466
| – | – | 0.02% | 108 |
|
|
2020
Q4 | $669K | Buy |
+3,466
| New | +$669K | 0.02% | 98 |
|
|
2020
Q3 | – | Sell |
-10,966
| Closed | -$1.76M | – | 93 |
|
|
2020
Q2 | $1.76M | Sell |
10,966
-421
| -4% | -$67.5K | 0.07% | 74 |
|
|
2020
Q1 | $3.42M | Buy |
11,387
+2,962
| +35% | +$889K | 0.16% | 59 |
|
|
2019
Q4 | $2.7M | Sell |
8,425
-20,964
| -71% | -$6.73M | 0.11% | 59 |
|
|
2019
Q3 | $11.2M | Sell |
29,389
-291
| -1% | -$111K | 0.68% | 36 |
|
|
2019
Q2 | $13.4M | Buy |
29,680
+21,255
| +252% | +$9.56M | 0.77% | 36 |
|
|
2019
Q1 | $4.4M | Sell |
8,425
-1,918
| -19% | -$1M | 0.3% | 51 |
|
|
2018
Q4 | $4.32M | Buy |
+10,343
| New | +$4.32M | 0.35% | 47 |
|